Skip to content
synovial sarcoma foundation
  • About
    • Mission
    • Initiatives
    • Affiliations
    • Leadership
    • Board of Directors
    • Medical Advisory Board
    • Careers
  • Resources
    • Synovial Sarcoma FAQ
    • Treatments
    • Clinical Trials & Therapies
    • Synovial Sarcoma Patient Survey
    • Synovial Sarcoma Tumor Board
    • Patient Stories
    • Patient Resources
    • Eddie’s Story
    • Sarcoma Awareness Month
    • Video Resources
  • Research Programs
    • Clinical Research
    • Tumor Glow
    • Synovial Sarcoma Registry
  • Latest News
Donate

Send us a note

Please fill out the form below and we will gladly respond as soon as possible.

    Development, Case Study

    Rare Synovial Sarcoma Cases Highlight New Limb-Sparing Reconstruction Approach

    May 29, 2026 ayushis Comments Off on Rare Synovial Sarcoma Cases Highlight New Limb-Sparing Reconstruction Approach
    A doctor wearing a white coat and stethoscope holds a glowing light bulb in one hand, symbolizing innovation or new ideas in healthcare.

    A new case report published in the World Journal of Surgical Oncology explored an innovative reconstruction technique for rare soft tissue sarcomas of the hand and foot, including synovial sarcoma. The study was authored by Naoya Terao, Naoki Oike, Takashi Ariizumi, and colleagues, with research conducted primarily through the Division of Orthopedic Surgery at Niigata University Graduate School of Medical and Dental Sciences alongside collaborators from multiple cancer and orthopedic centers across Japan. The report examined how a surgical approach called extracorporeal irradiation (ECI) helped preserve limb function after tumor removal while avoiding amputation or more invasive reconstruction procedures.

    Because synovial sarcoma in the hands and feet is extremely rare, treatment can be especially challenging. These areas contain complex anatomy, limited soft tissue, and important structures needed for movement and daily function.

    A Different Approach to Reconstruction

    The report described three patients who underwent additional surgery after initial tumor removal at other hospitals. Two of the patients were diagnosed with synovial sarcoma involving the hand and foot.

    To preserve function after removing the tumor, surgeons used a technique called extracorporeal irradiation (ECI).

    With this method:

    • Tumor-affected bone and tendon tissue are removed
    • The tissue is treated with high-dose radiation outside the body to destroy cancer cells
    • The patient’s own tissue is then reimplanted for reconstruction

    This approach may help preserve movement and avoid the need to take healthy tissue from other parts of the body.

    What the Study Found

    All three patients remained free of local recurrence during follow-up.

    Researchers also reported encouraging functional outcomes:

    • Patients were able to return to work and daily activities
    • Limb function was largely preserved
    • No amputations were required

    Some patients did require additional surgeries for issues such as tendon stiffness, bone healing, or flap adjustments, but overall outcomes were considered positive.

    Why This Matters for Synovial Sarcoma

    Synovial sarcoma is often treated with surgery aimed at completely removing the tumor while preserving as much function as possible.

    In rare locations like the hand or foot, reconstruction can be particularly difficult. This study highlights how newer limb-sparing surgical techniques may help improve both cancer control and quality of life for some patients.

    The report also reinforces several important lessons:

    • Early referral to specialized sarcoma centers matters
    • Accurate surgical planning is critical
    • Additional surgery may be needed after unplanned tumor removal
    • Preserving long-term function is an important part of sarcoma care

    Looking Ahead

    Although this was a very small case series, the findings suggest that extracorporeal irradiation reconstruction may become a valuable option for selected synovial sarcoma patients in the future.

    As surgical techniques and sarcoma care continue to advance, researchers hope to improve both survival and functional outcomes for patients facing rare and complex tumors.

    For more detailed information, please refer to the original publication. For more information about the Synovial Sarcoma Foundation, please visit our website.

    ayushis

    Post navigation

    Previous
    Next

    Search

    Categories

    • Black Flag Racing (2)
    • Case Study (3)
    • Children (1)
    • CHOP (3)
    • Development (11)
    • Dr. Theodore Laetsch (3)
    • Education (20)
    • Europe Expansion (1)
    • Healthcare (11)
    • Latest News (14)
    • Programs (1)
    • Rare Cancer (7)
    • Rare Cancer Funding (2)
    • Research (19)
    • Synovial Sarcoma Conference (2)
    • Synovial Sarcoma Registry (5)
    • Teresa Belluco (1)
    • Tumor Board (2)

    Recent posts

    • A close-up of a shiny, silver molecular model with connected spheres representing atoms, set against a blurred blue and white laboratory background.
      Then and Now: Decoding the Chromatin Machinery Behind Synovial Sarcoma
    • A scientist wearing protective gear, including a lab coat, mask, hair cover, and safety goggles, holds a pen and checks a clipboard while working in a laboratory setting with scientific equipment on the table.
      Synovial Sarcoma Foundation Funds New Data Staff Scientist Position at CHOP
    • A doctor wearing a stethoscope and a yellow ribbon holds hands with a smiling child dressed in yellow, symbolizing support and care in a bright, sunlit room.
      TECELRA Receives Full FDA Approval, Expands Access to Adolescents with Synovial Sarcoma

    Tags

    Afami-cel Afamitresgene autoleucel Cancer Research CHOP comprehensive genomic profiling sarcoma extracorporeal irradiation foot sarcoma hand sarcoma HLA typing sarcoma immunotherapy MAGE-A4 synovial sarcoma myxoid synovial sarcoma NY-ESO-1 synovial sarcoma Oncology precision medicine Rare Cancer rare cancer research rare cancer surgery rare disease rare soft tissue sarcoma research sarcoma clinical trials sarcoma reconstruction sarcoma research sarcoma treatment soft tissue sarcoma soft tissue sarcoma reconstruction solitary fibrous tumor SS18 SSX1 fusion gene Synovial Sarcoma synovial sarcoma biomarker testing synovial sarcoma diagnosis Synovial Sarcoma Foundation synovial sarcoma hand synovial sarcoma misdiagnosis synovial sarcoma molecular testing synovial sarcoma research synovial sarcoma surgery synovial sarcoma treatment synovial sarcoma vs extraskeletal myxoid chondrosarcoma T-Cell Therapy targeted therapy TECELRA Tecelra synovial sarcoma webinar

    Related posts

    A group photo collage introduces the Medical Advisory Board for the Synovial Sarcoma Foundation, featuring 11 professionals in business or medical attire, with the foundation's logo and branding text on a colorful background.
    Latest News

    Synovial Sarcoma Foundation Announces Formation of Medical Advisory Board

    June 22, 2026 ayushis Comments Off on Synovial Sarcoma Foundation Announces Formation of Medical Advisory Board

    11 Leading Oncologists and Researchers Unite to Accelerate Progress for Synovial Sarcoma Patients PHILADELPHIA [June 22, 2026] The Synovial Sarcoma Foundation (SSF) today announced the formation of its Medical Advisory Board, bringing together 11 internationally recognized clinicians and researchers to serve as the central coordinating body for synovial sarcoma research, treatment, and advocacy. The board […]

    A healthcare professional in blue scrubs holds the hand of a patient in bed, offering comfort and support in a bright, sunlit room.
    Research, Rare Cancer

    Research Highlights Importance of Patient-Centered Sarcoma Surveillance

    May 22, 2026 ayushis Comments Off on Research Highlights Importance of Patient-Centered Sarcoma Surveillance

    A 2022 study explored how sarcoma patients feel about long-term surveillance imaging after treatment, highlighting the emotional, financial, and practical challenges that can come with ongoing follow-up care. The study, led by Sarah C. Tepper, Anna K. Holten, Cara A. Cipriano, and colleagues evaluated patient concerns surrounding surveillance imaging through the “Sarcoma Surveillance Survey.” The […]

    A close-up view of two hands in blue surgical gloves passing a surgical instrument under bright operating room lights.
    Case Study, Education

    Study Finds Tumor Size and Surgical Margins are Key Drivers of Synovial Sarcoma Outcomes

    May 20, 2026 ayushis Comments Off on Study Finds Tumor Size and Surgical Margins are Key Drivers of Synovial Sarcoma Outcomes

    A new multi-center retrospective study from three major U.S. sarcoma centers has analyzed outcomes in patients with localized synovial sarcoma, making it one of the largest modern cohorts to examine how tumor characteristics and treatment modality affect recurrence and survival in this disease. The study, led by Stefano Testa, Maggie Yuxi Zhou, and colleagues from […]

    The Synovial Sarcoma Foundation is a registered 501(c)(3) nonprofit organization. Tax ID number is 33-4027591. Contributions to the Synovial Sarcoma Foundation are tax-deductible to the extent permitted by law.

    • Terms & conditions
    • Privacy policy
    synovial sarcoma foundation
    • community@synovialsarcoma.org
    1025 Thomas Jefferson St. NW, Suite W-3200, Washington DC 20007
    Facebook-f X-twitter Linkedin

    Navigation

    • About
    • Research Programs
    • Patient Stories
    • Resources

    Stay in touch